Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents

Arzneimittelforschung: Erstanwendung am Menschen in der Phase I

Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847

The complete genome sequence of the gastric pathogen Helicobacter pylori

Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529

DNA Topoisomerases: Structure, Function, and Mechanism

Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743

Identification and Structural Characterization of the ATP/ADP-Binding Site in the Hsp90 Molecular Chaperone

Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265

DNA gyrase: an enzyme that introduces superhelical turns into DNA.

Gellert, M., Mizuuchi, K., O'Dea, M. H., & Nash, H. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3872 · Cited by 1,204

Complete Genome Sequence of Treponema pallidum, the Syphilis Spirochete

Fraser, C. M., Norris, S. J., Weinstock, G. M., White, O., Sutton, G. G., Dodson, R., Gwinn, M., Hickey, E. K., Clayton, R., Ketchum, K. A., et al. (1998) · Science · doi:10.1126/science.281.5375.375 · Cited by 1,081

Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy

Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903

Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli

Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777

1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents

Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., & Brundage, R. P. (1962) · Journal of Medicinal and Pharmaceutical Chemistry · doi:10.1021/jm01240a021 · Cited by 766

DNA Gyrase and the Supercoiling of DNA

Cozzarelli, N. R. (1980) · Science · doi:10.1126/science.6243420 · Cited by 711

Structure-activity and structure-side-effect relationships for the quinolone antibacterials

Domagala, J. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.4.685 · Cited by 681

Emerging Mechanisms of Fluoroquinolone Resistance

Hooper, D. C. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010239 · Cited by 633

The fluoroquinolone antibacterials: past, present and future perspectives

Appelbaum, P. C., & Hunter, P. A. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00192-8 · Cited by 629

New topoisomerase essential for chromosome segregation in E. coli

Kato, J.-I., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., & Suzuki, H. (1990) · Cell · doi:10.1016/0092-8674(90)90172-b · Cited by 566

Mechanism of plasmid-mediated quinolone resistance

Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 564

Crystal structure of an N-terminal fragment of the DNA gyrase B protein

Wigley, D. B., Davies, G. J., Dodson, E. J., Maxwell, A., & Dodson, G. (1991) · Nature · doi:10.1038/351624a0 · Cited by 533

Mechanisms of fluoroquinolone resistance

Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488

Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids

Koga, H., Itoh, A., Murayama, S., Suzue, S., & Irikura, T. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00186a014 · Cited by 486

Crystal structure of the breakage–reunion domain of DNA gyrase

Cabral, J. H. M., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., & Liddington, R. C. (1997) · Nature · doi:10.1038/42294 · Cited by 456

Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model

Shen, L. L., Mitscher, L. A., Sharma, P. N., O'Donnell, T. J., Chu, D. W. T., Cooper, C. S., Rosen, T., & Pernet, A. G. (1989) · Biochemistry · doi:10.1021/bi00435a039 · Cited by 413

Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones

Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409

Quinolone antimicrobial agents

(1989) · International Journal of Biochemistry · doi:10.1016/0020-711x(89)90066-9 · Cited by 407

Quinolone Antimicrobial Agents

Neu, H. C. (1992) · Annual Review of Medicine · doi:10.1146/annurev.me.43.020192.002341 · Cited by 400

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

Shen, L. L., & Pernet, A. G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.307 · Cited by 369

Photophysics and photochemistry of fluoroquinolones

Albini, A., & Monti, S. (2003) · Chemical Society Reviews · doi:10.1039/b209220b · Cited by 329

Fluoroquinolones: Action and Resistance

Drlica, K., & Malik, M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452537 · Cited by 317

The Synthesis of Certain Substituted Quinolines and 5,6-Benzoquinolines

Gould, R. G., & Jacobs, W. A. (1939) · Journal of the American Chemical Society · doi:10.1021/ja01265a088 · Cited by 307

The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs

Ali, J. A., Jackson, A. P., Howells, A. J., & Maxwell, A. (1993) · Biochemistry · doi:10.1021/bi00061a033 · Cited by 303

Quinolone generations: natural history or natural selection?

Ball, P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020889 · Cited by 302

DNA gyrase: subunit structure and ATPase activity of the purified enzyme.

Mizuuchi, K., O'Dea, M. H., & Gellert, M. F. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.12.5960 · Cited by 292

Mechanisms of quinolone action and microbial response

Hawkey, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg207 · Cited by 288

Interactions of a Series of Fluoroquinolone Antibacterial Drugs with the Human Cardiac K+ Channel HERG

Kang, J., Wang, L., Chen, X.-L., Triggle, D. J., & Rampe, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12364-4 · Cited by 282

Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli

Yamagishi, J.-I., Yoshida, H., Yamayoshi, M., & Nakamura, S. (1986) · Molecular and General Genetics MGG · doi:10.1007/bf00331012 · Cited by 263

Emerging Plasmid-Mediated Quinolone Resistance Associated with the qnr Gene in Klebsiella pneumoniae Clinical Isolates in the United States

Wang, M., Sahm, D. F., Jacoby, G. A., & Hooper, D. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1295-1299.2004 · Cited by 243

Mycobacterium tuberculosis DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug Activity

Aubry, A., Pan, X.-S., Fisher, L. M., Jarlier, V., & Cambau, E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1281-1288.2004 · Cited by 240

Repair of DNA double-strand breaks in Escherichia coli, which requires recA function and the presence of a duplicate genome

Krasin, F., & Hutchinson, F. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90120-6 · Cited by 237

Molecular Mechanisms of Fluoroquinolone Resistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

Jalal, S., Ciofu, O., Høiby, N., Gotoh, N., & Wretlind, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.710-712.2000 · Cited by 236

The safety profile of the fluoroquinolones

Bertino, J., & Fish, D. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80053-3 · Cited by 218

DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae

Pan, X.-S., & Fisher, L. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2810 · Cited by 215

Fluoroquinolone Antimicrobials: Singlet Oxygen, Superoxide and Phototoxicity

Martinez, L. J., Sik, R. H., & Chignell, C. F. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb05217.x · Cited by 202

The F Plasmid CcdB Protein Induces Efficient ATP-dependent DNA Cleavage by Gyrase

Bernard, P., Kézdy, K. E., Van Melderen, L., Steyaert, J., Wyns, L., Pato, M. L., Higgins, P. N., & Couturier, M. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1609 · Cited by 201

DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli

Sreedharan, S., Oram, M., Jensen, B., Peterson, L. R., & Fisher, L. M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.7260-7262.1990 · Cited by 173

Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites

Akahane, K., Sekiguchi, M., Une, T., & Osada, Y. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1704 · Cited by 159

Temafloxacin Syndrome: Review of 95 Cases

Blum, M. D., Graham, D. J., & McCloskey, C. A. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.6.946 · Cited by 154

A topoisomerase from Escherichia coli related to DNA gyrase.

Brown, P. O., Peebles, C. L., & Cozzarelli, N. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6110 · Cited by 141

Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents

Chu, D. T. W., FERNANDES, P. B., Claiborne, A. K., Pihuleac, E., Nordeen, C. W., Maleczka, R. E., & Pernet, A. G. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00149a003 · Cited by 125

Quinolone-Binding Pocket of DNA Gyrase: Role of GyrB

Heddle, J. G., & Maxwell, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1805-1815.2002 · Cited by 125

Target Preference of 15 Quinolones againstStaphylococcus aureus, Based on Antibacterial Activities and Target Inhibition

Takei, M., Fukuda, H., Kishii, R., & Hosaka, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3544-3547.2001 · Cited by 123

Cytotoxicity of quinolones toward eukaryotic cells. Identification of topoisomerase II as the primary cellular target for the quinolone CP-115,953 in yeast.

Elsea, S. H., Osheroff, N., & Nitiss, J. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42185-0 · Cited by 123

The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition11Edited by J. Karn

Heddle, J. G., Blance, S. J., Zamble, D. B., Hollfelder, F., Miller, D. A., Wentzell, L. M., Walsh, C. T., & Maxwell, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4562 · Cited by 123

Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae : Contributions of Type II Topoisomerase Mutations and Efflux to Levels of Resistance

Bast, D. J., Low, D. E., Duncan, C. L., Kilburn, L., Mandell, L. A., Davidson, R., & de Azavedo, J. C. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3049-3054.2000 · Cited by 122

Mechanism of quinolone resistance in Staphylococcus aureus

Tanaka, M., Wang, T., Onodera, Y., Uchida, Y., & Sato, K. (2000) · Journal of Infection and Chemotherapy · doi:10.1007/s101560070010 · Cited by 107

Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin)

Mitscher, L. A., Sharma, P. N., Chu, D. T. W., Shen, L. L., & Pernet, A. G. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00395a017 · Cited by 102

Antimicrobial Activities of Mefloquine and a Series of Related Compounds

Kunin, C. M., & Ellis, W. Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.848-852.2000 · Cited by 100

The new generation of quinolones

(1991) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(91)90356-h · Cited by 96

Synthesis and antibacterial activities of substituted 7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids.

Hayakawa, I., HIRAMITSU, T., & Tanaka, Y. (1984) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.32.4907 · Cited by 94

DNA Cleavage Is Not Required for the Binding of Quinolone Drugs to the DNA Gyrase−DNA Complex

Critchlow, S. E., & Maxwell, A. (1996) · Biochemistry · doi:10.1021/bi9603175 · Cited by 89

Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin

Fresta, M., Guccione, S., Beccari, A. R., Furneri, P. M., & Puglisi, G. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00350-4 · Cited by 85

The Interaction of Drugs with DNA Gyrase: A Model for the Molecular Basis of Quinolone Action

Heddle, J. G., Barnard, F. M., Wentzell, L. M., & Maxwell, A. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033048 · Cited by 83

On the Effect of Covalently Appended Quinolones on Termini of DNA Duplexes

Tuma, J., Connors, W. H., Stitelman, D. H., & Richert, C. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0125117 · Cited by 80

FLUOROQUINOLONES

O’Donnell, J. A., & Gelone, S. P. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70260-9 · Cited by 79

Probing the Role of the ATP-Operated Clamp in the Strand-Passage Reaction of DNA Gyrase

Tingey, A. P., & Maxwell, A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.24.4868 · Cited by 74

Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems

Albertini, S., Chételat, A.-A., Miller, B. M., Muster, W., Pujadas, E., Strobel, R., & Gocke, E. (1995) · Mutagenesis · doi:10.1093/mutage/10.4.343 · Cited by 73

Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus

Hoshino, K., Sato, K., Une, T., & Osada, Y. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1816 · Cited by 72

Quinolone Resistance Mutations in Streptococcus pneumoniae GyrA and ParC Proteins: Mechanistic Insights into Quinolone Action from Enzymatic Analysis, Intracellular Levels, and Phenotypes of Wild-Type and Mutant Proteins

Pan, X.-S., Yagüe, G., & Fisher, L. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3140-3147.2001 · Cited by 70

GyrI: a counter‐defensive strategy against proteinaceous inhibitors of DNA gyrase

Chatterji, M., & Nagaraja, V. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf038 · Cited by 70

Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration

Patmore, L., Stuart, F., Mair, D., & Templeton, A. G. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00694-4 · Cited by 68

Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin

Vincent, J., Venitz, J., Teng, R., Baris, B. A., Willavize, S. A., Polzer, R. J., & Friedman, H. L. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.suppl_2.75 · Cited by 66

New Findings on the Structure-Phototoxicity Relationship and Photostability of Fluoroquinolones with Various Substituents at Position 1

Hayashi, N., Nakata, Y., & Yazaki, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.799-803.2004 · Cited by 63

Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system.

Ooie, T., Terasaki, T., Suzuki, H., & Sugiyama, Y. (1997) · PubMed · Cited by 61

Pharmacodynamics of the New Des-F(6)-QuinoloneGarenoxacin in a Murine Thigh InfectionModel

Andes, D. R., & Craig, W. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3935-3941.2003 · Cited by 56

Rate and Mechanism of the Oxidative Addition of Phenyl Iodide to Pd0 Ligated by Triphenylarsine: Evidence for the Formation of a T-Shaped Complex [PhPdI(AsPh3)] and for the Decelerating Effect of CH2=CH−SnBu3 by Formation of [Pd0(η2-CH2=CH−SnBu3)(AsPh3)2]

Amatore, C. A., Bucaille, A., Fuxa, A., Jutand, A., Meyer, G., & Ntepe, A. N. (2001) · Chemistry - A European Journal · doi:10.1002/1521-3765(20010518)7:10<2185::aid-chem2185>3.0.co;2-u · Cited by 55

DNA Cleavage Activities of Staphylococcus aureus Gyrase and Topoisomerase IV Stimulated by Quinolones and 2-Pyridones

Saiki, A. Y., Shen, L. L., Chen, C., Baranowski, J. L., & Lerner, C. G. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1574 · Cited by 51

CASE REPORT: Trovafloxacin Hepatotoxicity

Lazarczyk, D. A., Goldstein, N. S., & Gordon, S. C. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010741510046 · Cited by 47

Potent non-6-fluoro-substituted quinolone antibacterials: synthesis and biological activity

Ledoussal, B., BOUZARD, D., & Coroneos, E. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00079a028 · Cited by 44

Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents

Gradelski, E., Kolek, B., BONNER, D. P., Valera, L., Minassian, B., & Fung-Tomc, J. C. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00317-4 · Cited by 44

In vitro phototoxic properties of new 6-desfluoro and 6-fluoro-8-methylquinolones

Miolo, G., Viola, G., Vedaldi, D., et al. (2002) · Toxicology in Vitro · doi:10.1016/s0887-2333(02)00093-0 · Cited by 42

Quinolone-DNA Interaction: Sequence-Dependent Binding to Single-Stranded DNA Reflects the Interaction within the Gyrase-DNA Complex

Noble, C. G., Barnard, F. M., & Maxwell, A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.854-862.2003 · Cited by 40

Treatment of Sexually Transmitted Bacterial Diseases in Pregnant Women

Donders, G. G. G. (2000) · Drugs · doi:10.2165/00003495-200059030-00005 · Cited by 37

Photochemical mutagenicity of phototoxic and photochemically carcinogenic fluoroquinolones in comparison with the photostable moxifloxacin

Jeffrey, A. M., Shao, L., Brendler‐Schwaab, S., Schlüter, G., & Williams, G. M. (2000) · Archives of Toxicology · doi:10.1007/s002040000162 · Cited by 35

Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol [1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)

Coughlin, S. A., Danz, D. W., Robinson, R. G., Klingbeil, K. M., Wentland, M. P., Corbett, T. H., Waud, W. R., Zwelling, L. A., Altschuler, E. M., Bales, E. S., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00016-s · Cited by 35

Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor

Nakada, N., Gmünder, H., Hirata, T., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.1966 · Cited by 33

Design of New Topoisomerase II Inhibitors Based upon a Quinobenzoxazine Self-Assembly Model

Zeng, Q., Kwok, Y., Kerwin, S. M., Mangold, G., & Hurley, L. H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980265c · Cited by 32

Testing Potential Gyrase Inhibitors of Bacterial DNA Gyrase: A Comparison of the Supercoiling Inhibition Assay and "Cleavable Complex" Assay

Barrett, J. F., Bernstein, J. I., Krause, H. M., et al. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1493 · Cited by 31

Drug Interactions with Clinafloxacin

Randinitis, E. J., Alvey, C. W., Koup, J. R., Rausch, G., Abel, R. B., Bron, N. J., Hounslow, N. J., Vassos, A. B., & Sedman, A. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2543-2552.2001 · Cited by 29

Action of Quinolones against Staphylococcus aureus Topoisomerase IV: Basis for DNA Cleavage Enhancement

Anderson, V. E., Zaniewski, R. P., Kaczmarek, F. S., et al. (2000) · Biochemistry · doi:10.1021/bi992302n · Cited by 27

Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts

Fresta, M., Spadaro, A., Cerniglia, G., Ropero, I., Puglisi, G., & Furneri, P. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1372 · Cited by 27

Pharmacokinetics and metabolism of single oral doses of trovafloxacin

Vincent, J., Teng, R., Dalvie, D., & Friedman, H. L. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00213-x · Cited by 26

A biochemical analysis of the interaction of DNA gyrase with the bacteriophage Mu, pSC101 and pBR322 strong gyrase sites: the role of DNA sequence in modulating gyrase supercoiling and biological activity

Oram, M., Howells, A. J., Maxwell, A., et al. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03690.x · Cited by 25

Mechanisms and spread of fluoroquinolone resistancein

Varon, E., & Gutmann, L. (2000) · Research in Microbiology · doi:10.1016/s0923-2508(00)00167-4 · Cited by 18

A Laser Flash Photolysis and Pulse Radiolysis Study of Primary Photochemical Processes of Flumequine¶

Bazin, M., Boscá, F., Marin, M. L., Miranda, M. A., Patterson, L. K., & Santus, R. C. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720451alfpap2.0.co2 · Cited by 17

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847

Mechanism of Quinolone Action and Resistance

Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282

Quinolone antibiotics

Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785

Emerging Targets in Photopharmacology

Lerch, M. M., Hansen, M. J., van Dam, G. M., Szymanski, W., & Feringa, B. L. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601931 · Cited by 675

Antituberculosis drugs: Ten years of research

Janin, Y. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.030 · Cited by 485